Real-Time Light-Guided Vocal Fold Injection via the Cricothyroid Membrane in Unilateral Vocal Fold Paralysis: A Human Pilot Study

Objectives. Vocal fold injection (VFI) via the cricothyroid (CT) membrane is used to treat various diseases affecting the vocal folds. The technical challenges of this technique are mainly related to the invisibility of the needle. Real-time light-guided VFI (RL-VFI) was recently developed for injec...

Full description

Bibliographic Details
Main Authors: Gene Huh, Pil Geun Jang, Seung Hoon Han, Ramla Talib Mohammad, Woo Jin Jeong, Wonjae Cha
Format: Article
Language:English
Published: Korean Society of Otorhinolaryngology-Head and Neck Surgery 2022-08-01
Series:Clinical and Experimental Otorhinolaryngology
Subjects:
Online Access:http://e-ceo.org/upload/pdf/ceo-2021-02264.pdf
_version_ 1817986543090925568
author Gene Huh
Pil Geun Jang
Seung Hoon Han
Ramla Talib Mohammad
Woo Jin Jeong
Wonjae Cha
author_facet Gene Huh
Pil Geun Jang
Seung Hoon Han
Ramla Talib Mohammad
Woo Jin Jeong
Wonjae Cha
author_sort Gene Huh
collection DOAJ
description Objectives. Vocal fold injection (VFI) via the cricothyroid (CT) membrane is used to treat various diseases affecting the vocal folds. The technical challenges of this technique are mainly related to the invisibility of the needle. Real-time light-guided VFI (RL-VFI) was recently developed for injection under simultaneous light guidance in the CT approach. Herein, we present the first clinical trial of RL-VFI, in which we investigated the feasibility and safety of this new technique in unilateral vocal fold paralysis (VFP). Methods. This prospective pilot study enrolled 40 patients, who were treated with RL-VFI for unilateral VFP between September 2020 and August 2021. Adverse events were monitored during the procedure and for 4 weeks postoperatively. The Voice Handicap Index-10, the GRBAS (grade, roughness, breathiness, asthenia, and strain) scale, aerodynamic studies, and acoustic analyses were evaluated to compare the voice improvement after 4 weeks with the baseline values. Results. The needle tip was intuitively identified by the red light. The mean procedure time was 95.6±40.6 seconds for the initial injection, while the additional injection required 79.2±70.5 seconds. The injection was performed under light guidance without additional manipulation after the needle reached the intended point. No acute or delayed adverse events were reported. Among the 40 patients, 36 completed voice analyses after 4 weeks. Subjective and objective voice parameters, including the Voice Handicap Index-10, GRBAS scale, maximum phonation time, mean expiratory airflow, fundamental frequency, jitter, shimmer, and noise-to-harmonics ratio improved significantly after RL-VFI (P<0.05), while the expiratory volume was maintained. Conclusion. RL-VFI is feasible and safe for treating patients with unilateral VFP. This technique is anticipated to improve the precision and safety of the CT approach in the treatment of unilateral VFP. This study provides a rationale for further structured clinical studies.
first_indexed 2024-04-14T00:11:26Z
format Article
id doaj.art-6c77a8ed41aa4c0d8bb2847782bd93ba
institution Directory Open Access Journal
issn 1976-8710
2005-0720
language English
last_indexed 2024-04-14T00:11:26Z
publishDate 2022-08-01
publisher Korean Society of Otorhinolaryngology-Head and Neck Surgery
record_format Article
series Clinical and Experimental Otorhinolaryngology
spelling doaj.art-6c77a8ed41aa4c0d8bb2847782bd93ba2022-12-22T02:23:20ZengKorean Society of Otorhinolaryngology-Head and Neck SurgeryClinical and Experimental Otorhinolaryngology1976-87102005-07202022-08-0115326427210.21053/ceo.2021.02264822Real-Time Light-Guided Vocal Fold Injection via the Cricothyroid Membrane in Unilateral Vocal Fold Paralysis: A Human Pilot StudyGene Huh0Pil Geun Jang1Seung Hoon Han2Ramla Talib Mohammad3Woo Jin Jeong4Wonjae Cha5 Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Bundang Hospital, Seongnam, Korea Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Bundang Hospital, Seongnam, Korea Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Bundang Hospital, Seongnam, Korea Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Bundang Hospital, Seongnam, Korea Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Bundang Hospital, Seongnam, Korea Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Bundang Hospital, Seongnam, KoreaObjectives. Vocal fold injection (VFI) via the cricothyroid (CT) membrane is used to treat various diseases affecting the vocal folds. The technical challenges of this technique are mainly related to the invisibility of the needle. Real-time light-guided VFI (RL-VFI) was recently developed for injection under simultaneous light guidance in the CT approach. Herein, we present the first clinical trial of RL-VFI, in which we investigated the feasibility and safety of this new technique in unilateral vocal fold paralysis (VFP). Methods. This prospective pilot study enrolled 40 patients, who were treated with RL-VFI for unilateral VFP between September 2020 and August 2021. Adverse events were monitored during the procedure and for 4 weeks postoperatively. The Voice Handicap Index-10, the GRBAS (grade, roughness, breathiness, asthenia, and strain) scale, aerodynamic studies, and acoustic analyses were evaluated to compare the voice improvement after 4 weeks with the baseline values. Results. The needle tip was intuitively identified by the red light. The mean procedure time was 95.6±40.6 seconds for the initial injection, while the additional injection required 79.2±70.5 seconds. The injection was performed under light guidance without additional manipulation after the needle reached the intended point. No acute or delayed adverse events were reported. Among the 40 patients, 36 completed voice analyses after 4 weeks. Subjective and objective voice parameters, including the Voice Handicap Index-10, GRBAS scale, maximum phonation time, mean expiratory airflow, fundamental frequency, jitter, shimmer, and noise-to-harmonics ratio improved significantly after RL-VFI (P<0.05), while the expiratory volume was maintained. Conclusion. RL-VFI is feasible and safe for treating patients with unilateral VFP. This technique is anticipated to improve the precision and safety of the CT approach in the treatment of unilateral VFP. This study provides a rationale for further structured clinical studies.http://e-ceo.org/upload/pdf/ceo-2021-02264.pdfvocal fold palsyunilateral vocal cord paralysismedialization laryngoplastylaryngoscopic surgical procedure
spellingShingle Gene Huh
Pil Geun Jang
Seung Hoon Han
Ramla Talib Mohammad
Woo Jin Jeong
Wonjae Cha
Real-Time Light-Guided Vocal Fold Injection via the Cricothyroid Membrane in Unilateral Vocal Fold Paralysis: A Human Pilot Study
Clinical and Experimental Otorhinolaryngology
vocal fold palsy
unilateral vocal cord paralysis
medialization laryngoplasty
laryngoscopic surgical procedure
title Real-Time Light-Guided Vocal Fold Injection via the Cricothyroid Membrane in Unilateral Vocal Fold Paralysis: A Human Pilot Study
title_full Real-Time Light-Guided Vocal Fold Injection via the Cricothyroid Membrane in Unilateral Vocal Fold Paralysis: A Human Pilot Study
title_fullStr Real-Time Light-Guided Vocal Fold Injection via the Cricothyroid Membrane in Unilateral Vocal Fold Paralysis: A Human Pilot Study
title_full_unstemmed Real-Time Light-Guided Vocal Fold Injection via the Cricothyroid Membrane in Unilateral Vocal Fold Paralysis: A Human Pilot Study
title_short Real-Time Light-Guided Vocal Fold Injection via the Cricothyroid Membrane in Unilateral Vocal Fold Paralysis: A Human Pilot Study
title_sort real time light guided vocal fold injection via the cricothyroid membrane in unilateral vocal fold paralysis a human pilot study
topic vocal fold palsy
unilateral vocal cord paralysis
medialization laryngoplasty
laryngoscopic surgical procedure
url http://e-ceo.org/upload/pdf/ceo-2021-02264.pdf
work_keys_str_mv AT genehuh realtimelightguidedvocalfoldinjectionviathecricothyroidmembraneinunilateralvocalfoldparalysisahumanpilotstudy
AT pilgeunjang realtimelightguidedvocalfoldinjectionviathecricothyroidmembraneinunilateralvocalfoldparalysisahumanpilotstudy
AT seunghoonhan realtimelightguidedvocalfoldinjectionviathecricothyroidmembraneinunilateralvocalfoldparalysisahumanpilotstudy
AT ramlatalibmohammad realtimelightguidedvocalfoldinjectionviathecricothyroidmembraneinunilateralvocalfoldparalysisahumanpilotstudy
AT woojinjeong realtimelightguidedvocalfoldinjectionviathecricothyroidmembraneinunilateralvocalfoldparalysisahumanpilotstudy
AT wonjaecha realtimelightguidedvocalfoldinjectionviathecricothyroidmembraneinunilateralvocalfoldparalysisahumanpilotstudy